Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cardiology

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2015.01.086PMID 25705006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases].

  2015cited by this paper
• A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.

  2015cited by this paper
• Multidetector computed tomography of congenital aortic abnormalities.

  2014cited by this paper
• Major adverse maternal cardiovascular-related events in those with aortopathies. What should we expect?

  2014cited by this paper
• Aortic biomechanics by magnetic resonance: early markers of aortic disease in Marfan syndrome regardless of aortic dilatation?

  2014cited by this paper
• CT and MRI assessment of the aortic root and ascending aorta.

  2013cited by this paper
• Prosthesis sizing for transcatheter aortic valve implantation--comparison of three dimensional transesophageal echocardiography with multislice computed tomography.

  2013cited by this paper
• Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy

  2013cited by this paper
• Aortic Event Rate in the Marfan Population: A Cohort Study

  2012cited by this paper
• Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard.

  2012cited by this paper
• Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

  2012cited by this paper
• The translational science of Marfan syndrome

  2011cited by this paper
• Echocardiography in aortic diseases: EAE recommendations for clinical practice.

  2010cited by this paper
• Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

  2010cited by this paper
• Thoracic aortic aneurysm clinically pertinent controversies and uncertainties.

  2010cited by this paper
• 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame

  2010cited by this paper
• Aortic Root Measurement by Cardiovascular Magnetic Resonance: Specification of Planes and Lines of Measurement and Corresponding Normal Values

  2008cited by this paper
• Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

  2006cited by this paper
• Radiation exposure during cardiac CT: effective doses at multi-detector row CT and electron-beam CT.

  2003cited by this paper
• Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size.

  2002cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• AKUFO AND IBARAPA.

  1965cited by this paper

• Perivascular inflammation in the progression of aortic aneurysms in Marfan syndrome

  2025cites this paper
• 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.

  2024cites this paper
• Updated 2022 ACC/AHA Guideline Improves Concordance Between TTE and CT in Monitoring Marfan Snydrome and Related Disorders, but Relevant Measurement Differences Remain Frequent

  2024cites this paper
• Basic Guidelines for the Study of Aortic Pathology from de “Vascular diagnosis” Chapter

  2024cites this paper
• Approach to the Patient with Acute Aortic Syndromes in Light of the New Consensus Statement on Multimodality Imaging in Thoracic Aortic Diseases

  2023cites this paper
• Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases.

  2023cites this paper
• Discrepancy of echocardiography and computed tomography in initial assessment and 2-year follow-up for monitoring Marfan syndrome and related disorders

  2022cites this paper
• Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

  2022cites this paper
• HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD) a statement from the HTAD working group of VASCERN.

  2022cites this paper
• Assessment of aortic diameter in Marfan patients: intraindividual comparison of 3D-Dixon and 2D-SSFP magnetic resonance imaging

  2022cites this paper
• Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías

  2022cites this paper
• 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

  2021cites this paper
• Marfan syndrome

  2021cites this paper
• 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

  2021cites this paper
• On the Role and Effects of Uncertainties in Cardiovascular in silico Analyses

  2021cites this paper
• 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

  2021cites this paper
• Increased visceral arterial tortuosity in Marfan syndrome

  2020cites this paper
• Individual, expected diameters of the ascending aorta and prevalence of dilations in a study-population aged 60–74 years: a DANCAVAS substudy

  2020cites this paper
• Reliability of non-contrast magnetic resonance angiography-derived aortic diameters in Marfan patients: comparison of inner vs. outer vessel wall measurements

  2020cites this paper
• Pathogenic FBN1 Genetic Variation and Aortic Dissection in Patients With Marfan Syndrome.

  2020cites this paper
• Europea de Cardiología ( ESC ) y la European Association for CardioThoracic Surgery ( EACTS )

  2019cites this paper
• Echocardiographic Assessment of the Aorta

  2018cites this paper
• Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías

  2018cites this paper
• 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

  2018cites this paper
• [2017 ESC/EACTS Guidelines for the management of valvular heart disease].

  2017cites this paper
• 2017 ESC/EACTS Guidelines for the management of valvular heart disease.

  2017cites this paper
• Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European Association for CardioThoracic Surgery ( EACTS )

  2017cites this paper
• 2017 ESC/EACTS Guidelines for the management of valvular heart disease.

  2017cites this paper
• Oral anticoagulant therapy and thrombosis. A case of failure of therapy with vitamin K antagonists.

  2016cites this paper
• CT and MRI assessment of the aortic root and ascending aorta.

  2013cites this paper